Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
News » Short term use of AST to treat prostate cancer provides survival benefits without significant impact of side effects
 

Short term use of AST to treat prostate cancer provides survival benefits without significant impact of side effects

Localised prostate cancer responds better to a combined treatment of radiation therapy and six months of androgen suppression therapy (AST) claims a recent study. The involvement of AST improves survival rates but can have long-term side effects such as osteopenia, memory problems, attention deficits, disrupted heart rhythm, anemia, muscle loss, increase in body fat, hot flashes and impotence. Thus, the study claims that a short 6 month course of AST may provide survival benefits without significant negative side effects.

Source: summary of medical news story as reported by Onlypunjab

Related Disease Topics:

Article Source Details

About: Short term use of AST to treat prostate cancer provides survival benefits without significant impact of side effects

Date: 25 October 2004

Source: Onlypunjab

URL: http://www.onlypunjab.com/fullstory1004-insight-Survival+rates+improve+for+some+men-status-22-newsID-1528.html

Related Medical Topics

This summary article refers to the following medical categories:

More News Topics

  • 3 year old permanently damaged by wrong diagnosis of Rocky Mountain Spotted Fever
  • 3.2 million paid by cigarette company to a sufferer of chronic emphysema
  • 30 percent of emergency department patients report depression during the past year
  • 393,000 paid to family for medical malpractice
  • 4,000 diagnosed cases of brittle bone disease in the UK
  • 40 health professionals fail to diagnose brain tumor
  • 40 percent of city's young children have asthma
  • 40 percent of UK epilepsy sufferers taking epilepsy drugs unnecessarily
  • 44 men unsure of whether they have prostate cancer due to biopsy problems
  • 450,000 settlement over spinal surgery complications
  • 5 commonly prescribed drugs face further evaluations following health warnings
  • 5 year old children being treated for depression
  • 5.2 million asthmatics in the UK
  • 500,000 settlement over lack of monitoring of warfarin therapy
  •  

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise